Parallel Proceedings Think Tank: Winning Strategies for Navigating the District Court and Inter Parte Review (IPR)

Peter Waibel
Head, US Patent Litigation
Novartis Pharmaceuticals Corporation

Dan Minion
Partner
Venable

Eric W. Dittmann
Partner and Global Vice-Chair, Intellectual Property
Paul Hastings LLP

Kathleen B. Carr
Partner
McCarter & English, LLP

Gerald J. Flattmann, Jr.
Partner
King & Spalding LLP
- Developing new strategies for parallel proceedings in the District Courts and PTAB in view of a single standard
- Weighing the future of parallel proceedings in view of a single standard adoption
- Considering the takeaways from the patent challenger’s perspective in addition to the patentee perspective
- Devising strategies relative to the filing of an IPR or similar proceeding during the pendency of District Court litigation
- Formulating strategies based on type of pharmaceutical patent
- Establishing jurisdiction at the PTAB
- Special considerations for ex-U.S. parties
- Developing sound discovery strategies relative to dual proceedings
- Evaluating chances of getting a stay granted in the District Court
- Managing experts and use of experts in both forums
- Appealing decisions in both forums